Khatri A - Search Results

1

Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.

Gopalakrishnan SM, Polepally AR, Mensing S, Khatri A, Menon RM. Gopalakrishnan SM, et al. Among authors: khatri a. Clin Pharmacokinet. 2017 Jan;56(1):1-10. doi: 10.1007/s40262-016-0423-2. Clin Pharmacokinet. 2017. PMID: 27314261 Clinical Trial.

2

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir.

Menon RM, Badri PS, Wang T, Polepally AR, Zha J, Khatri A, Wang H, Hu B, Coakley EP, Podsadecki TJ, Awni WM, Dutta S. Menon RM, et al. Among authors: khatri a. J Hepatol. 2015 Jul;63(1):20-9. doi: 10.1016/j.jhep.2015.01.026. Epub 2015 Jan 31. J Hepatol. 2015. PMID: 25646891 Free article. Clinical Trial.

3

Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment.

Khatri A, Menon RM, Marbury TC, Lawitz EJ, Podsadecki TJ, Mullally VM, Ding B, Awni WM, Bernstein BM, Dutta S. Khatri A, et al. J Hepatol. 2015 Oct;63(4):805-12. doi: 10.1016/j.jhep.2015.05.029. Epub 2015 Jun 10. J Hepatol. 2015. PMID: 26070406 Clinical Trial.

4

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir.

Badri PS, Dutta S, Wang H, Podsadecki TJ, Polepally AR, Khatri A, Zha J, Chiu YL, Awni WM, Menon RM. Badri PS, et al. Among authors: khatri a. Antimicrob Agents Chemother. 2015 Oct 12;60(1):105-14. doi: 10.1128/AAC.01778-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26459906 Free PMC article. Clinical Trial.

5

Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies.

Mensing S, Polepally AR, König D, Khatri A, Liu W, Podsadecki TJ, Awni WM, Menon RM, Dutta S. Mensing S, et al. Among authors: khatri a. AAPS J. 2016 Jan;18(1):270-80. doi: 10.1208/s12248-015-9846-1. Epub 2015 Nov 23. AAPS J. 2016. PMID: 26597291 Free PMC article.

6

Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.

Khatri A, Dutta S, Wang H, Podsadecki T, Trinh R, Awni W, Menon R. Khatri A, et al. Clin Infect Dis. 2016 Apr 15;62(8):972-9. doi: 10.1093/cid/civ1213. Epub 2016 Jan 5. Clin Infect Dis. 2016. PMID: 26740513 Clinical Trial.

7

Drug-Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers.

Polepally AR, King JR, Ding B, Shuster DL, Dumas EO, Khatri A, Chiu YL, Podsadecki TJ, Menon RM. Polepally AR, et al. Among authors: khatri a. Clin Pharmacokinet. 2016 Aug;55(8):1003-14. doi: 10.1007/s40262-016-0373-8. Clin Pharmacokinet. 2016. PMID: 26895022 Free PMC article. Clinical Trial.

8

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.

Polepally AR, Mensing S, Khatri A, Beck D, Liu W, Awni WM, Menon RM, Dutta S. Polepally AR, et al. Among authors: khatri a. Clin Pharmacokinet. 2016 Sep;55(9):1091-101. doi: 10.1007/s40262-016-0385-4. Clin Pharmacokinet. 2016. PMID: 27000758 Clinical Trial.

9

Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study.

Gopalakrishnan S, Khatri A, Mensing S, Redman R, Menon R, Zha J. Gopalakrishnan S, et al. Among authors: khatri a. Adv Ther. 2016 Apr;33(4):670-83. doi: 10.1007/s12325-016-0320-y. Epub 2016 Mar 21. Adv Ther. 2016. PMID: 27084721 Clinical Trial.

10

Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected Patients.

Khatri A, Mensing S, Podsadecki T, Awni W, Menon R, Dutta S. Khatri A, et al. Clin Drug Investig. 2016 Aug;36(8):625-35. doi: 10.1007/s40261-016-0407-x. Clin Drug Investig. 2016. PMID: 27153823 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters